Skip to search formSkip to main contentSkip to account menu

HMPL-004

Known as: Andrographis paniculata extract, HMPL-004 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Plant Extracts

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Emerging treatments for ulcerative colitis: a systematic review
Abstract Objectives: Various investigational medicinal products have been developed for ulcerative colitis (UC). Our aim was to… 
2011
2011
IBD: Potential herbal alternative to mesalazine for ulcerative colitis
  • R. Thompson
  • Nature Reviews Gastroenterology &Hepatology
  • 2011
  • Corpus ID: 32286836
HMPL-004, an extract of Andrographis paniculata, has an efficacy similar to mesalazine for the treatment of ulcerative colitis… 
2011
2011
Mode of Action of HMPL-004 (Andrographis Paniculata Extract) in the Prevention of Murine Colitis: Blockage of T Cell Proliferation and TH1/ TH17 Responses
2011
2011
Actualizacion en el tratamiento de la colitis ulcerosa
2011
2011
Andrographis paniculata extract versus mesalazine for the treatment of active ulcerative colitis
Tang T, Targan SR, Xu C, Byers VS, Sandborn WJ. Randomized clinical trial: herbal extract HMPL-004 in active ulcerative… 
2011
2011
F1000Prime recommendation of Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine.
  • 2011
  • Corpus ID: 86855318
2010
2010
847x Double Blind Placebo Controlled Phase IIB Trial of HMPL-004 (Andrographis Paniculata Extract) in Active Mild to Moderate Ulcerative Colitis (UC)
2010
2010
Randomized, Double-blind, Placebo-Controlled Trial of Andrographis Paniculata Extract (HMPL-004) in Patients with Moderately Active Crohnʼs Disease: 1180
2009
2009
M1666 Anti-Inflammatory Effects of HMPL-004 Are Mediated By the Inhibition of Multiple Targets
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)